It is mainly used to inhibit the replication of porcine reproductive and respiratory syndrome (PRRS) virus, stabilize PRRS in pig farms, and prevent and treat Mycoplasma hyopneumoniae, infectious pleuropneumonia, Streptococcus, ileitis, spirochetosis, etc. For poultry, it can: control respiratory tract infections and kill mycoplasma, regulate the intestine to promote growth, enhance immunity during the immune gap period, improve the healthy chick rate and uniformity, laying a good foundation for the later growth and development of commercial broilers.
Tylvalosin tartrate has resistant activity against many Gram-positive bacteria and certain negative bacteria, including mycoplasma, vibrio, spirochete and large viruses. It has unique curative effects on Mycoplasma gallisepticum in chickens, swine enzootic pneumonia, swine dysentery, etc., and is suitable for the prevention and treatment of atrophic rhinitis, fowl cholera, chronic respiratory diseases in chickens, pneumonia caused by Mycoplasma bovis in calves and other diseases. This product has a wider safety margin than tylosin and is an ideal drug with obvious curative effects on mycoplasma diseases in poultry and livestock.
Directly kill mycoplasma and prevent and control respiratory disease syndrome;
Inhibit the replication of porcine reproductive and respiratory syndrome (PRRS) virus;
Enhance non-specific immunity;
A specific drug for the prevention and treatment of porcine proliferative enteritis (ileitis) and swine dysentery;
Promote growth;
It is the only optimal western medicine against PRRS.
视频号二维码
公众号
联系方式
视频号二维码
公众号
